The TΑp63/BCL2 axis represents a novel mechanism of clinical aggressiveness in chronic lymphocytic leukemia.
Laidou S, Grigoriadis D, Papanikolaou S, Foutadakis S, Ntoufa S, Tsagiopoulou M, Vatsellas G, Anagnostopoulos A, Kouvatsi A, Stavroyianni N, Psomopoulos F, Makris AM, Agelopoulos M, Thanos D, Chatzidimitriou A, Papakonstantinou N, Stamatopoulos K.
Laidou S, et al. Among authors: agelopoulos m.
Blood Adv. 2022 Apr 26;6(8):2646-2656. doi: 10.1182/bloodadvances.2021006348.
Blood Adv. 2022.
PMID: 35235952
Free PMC article.